Skip to main content
WEAV
NYSE Technology

Weave Communications Reports Strong Q4 & Full Year 2025 Results, Projects Continued Growth in 2026

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$5.7
Mkt Cap
$444.747M
52W Low
$5.37
52W High
$17.225
52W Position info
6.1% above low
Off High info
67% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

WEAV is trading near its 52-week low of $5.37 (6.1% above the low).

Summary

Weave Communications announced strong financial results for Q4 and full year 2025, featuring 17% revenue growth and significant improvements in profitability and free cash flow, alongside positive guidance for 2026.


Key Events · Earnings and Guidance · WEAV

  • Strong Q4 2025 Revenue Growth

    Total revenue increased 17.0% year-over-year to $63.4 million in the fourth quarter of 2025.

  • Significant Full Year 2025 Profitability Improvement

    Non-GAAP income from operations grew to $4.1 million for the full year 2025, a substantial increase from $0.8 million in 2024, while GAAP net loss narrowed to $28.1 million from $28.3 million.

  • Positive Full Year 2025 Free Cash Flow

    The company generated $12.9 million in free cash flow for the full year 2025, an increase of $2.5 million year-over-year.

  • Solid 2026 Financial Outlook

    Management provided full-year 2026 revenue guidance of $273.0 million to $276.0 million and non-GAAP income from operations guidance of $8.0 million to $12.0 million.


Analysis · WEAV · Technology

Weave Communications demonstrated strong operational execution in 2025, marked by consistent 17% year-over-year revenue growth in both the fourth quarter and full year. A notable achievement is the significant improvement in profitability, with non-GAAP income from operations increasing five-fold for the full year and GAAP net losses narrowing. The generation of positive free cash flow for the full year further strengthens the company's financial position. The provided 2026 guidance projects continued revenue expansion and a substantial increase in non-GAAP operating income, signaling confidence in sustained growth and profitability. Strategic initiatives, including new partnerships and product innovations, are expected to enhance its market position in healthcare SaaS.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 28.9% of the 1666 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WEAV was trading at $5.70 on NYSE in the Technology sector, with a market capitalization of approximately $444.7M. The 52-week trading range was $5.37 to $17.23. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WEAV - Latest Insights

WEAV
Sep 25, 2026, 8:55 AM EDT
Filing Type: DEFM14A
Importance Score:
7
Price at Filing: $7.34
Real-time Price: $7.37 info
Change: +$0.030 (+0.41%) info
Market Cap: $592.92M info
WEAV
Sep 21, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.33
Real-time Price: $7.37 info
Change: +$0.040 (+0.55%) info
Market Cap: $592.92M info
WEAV
Sep 15, 2026, 4:47 PM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $7.33
Real-time Price: $7.37 info
Change: +$0.040 (+0.55%) info
Market Cap: $592.92M info
WEAV
Aug 19, 2026, 6:34 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $7.29
Real-time Price: $7.37 info
Change: +$0.080 (+1%) info
Market Cap: $592.92M info
WEAV
Aug 19, 2026, 9:01 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.29
Real-time Price: $7.37 info
Change: +$0.0803 (+1%) info
Market Cap: $592.92M info